• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

负载法尼醇或香叶醇的脂质纳米颗粒以增强MCR-1对黏菌素的敏感性

Lipid Nanoparticles Loaded with Farnesol or Geraniol to Enhance the Susceptibility of MCR-1 to Colistin.

作者信息

Valcourt Chantal, Buyck Julien M, Grégoire Nicolas, Couet William, Marchand Sandrine, Tewes Frédéric

机构信息

INSERM U1070 "Pharmacology of Anti-Infective Agents", 1 rue Georges Bonnet, Pôle Biologie Santé, 86022 Poitiers, France.

UFR Médecine-Pharmacie Université de Poitiers, 6 rue de la Milétrie, TSA 51115, 86073 Poitiers, France.

出版信息

Pharmaceutics. 2021 Nov 3;13(11):1849. doi: 10.3390/pharmaceutics13111849.

DOI:10.3390/pharmaceutics13111849
PMID:34834268
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8625850/
Abstract

Resistance to colistin, one of the antibiotics of last resort against multidrug-resistant Gram-negative bacteria, is increasingly reported. Notably, MCR plasmids discovered in 2015 have now been reported worldwide in humans. To keep this antibiotic of last resort efficient, a way to tackle this mechanism seems essential. Terpene alcohols such as farnesol have been shown to improve the efficacy of some antibiotics. However, their high lipophilicity makes them difficult to use. This problem can be solved by encapsulating them in water-dispersible lipid nanoparticles (LNPs). The aim of this study was to discover, using checkerboard tests and time-kill curve experiments, an association between colistin and farnesol or geraniol loaded in LNPs, which would improve the efficacy of colistin against and, in particular, MCR-1 transconjugants. Then, the effect of the combination on inner membrane permeabilisation was evaluated using propidium iodide (PI) uptake and compared to human red blood cells plasma membrane permeabilisation. Both terpene alcohols were able to restore the susceptibility of J53 MCR-1 to colistin with the same efficacy (E = 16, i.e., colistin MIC was decreased from 8 to 0.5 mg/L). However, with an EC of 2.69 mg/L, farnesol was more potent than geraniol (EC = 39.49 mg/L). Time-kill studies showed a bactericidal effect on MCR-1 transconjugant 6 h after incubation, with no regrowth up to 30 h in the presence of 1 mg/L colistin (1/8 MIC) and 60 mg/L or 200 mg/L farnesol or geraniol, respectively. Colistin alone was more potent in increasing PI uptake rate in the susceptible strain (EC = 0.86 ± 0.08 mg/L) than in the MCR-1 one (EC = 7.38 ± 0.85 mg/L). Against the MCR-1 strain, farnesol-loaded LNP at 60 mg/L enhanced the colistin-induced inner membrane permeabilization effect up to 5-fold and also increased its potency as shown by the decrease in its EC from 7.38 ± 0.85 mg/L to 2.69 ± 0.25 mg/L. Importantly, no hemolysis was observed for LNPs loaded with farnesol or geraniol, alone or in combination with colistin, at the concentrations showing the maximum decrease in colistin MICs. The results presented here indicate that farnesol-loaded LNPs should be studied as combination therapy with colistin to prevent the development of resistance to this antibiotic of last resort.

摘要

对黏菌素(一种针对多重耐药革兰氏阴性菌的最后一道防线抗生素)的耐药性报道日益增多。值得注意的是,2015年发现的MCR质粒现已在全球范围内的人类中被报道。为了使这种最后一道防线的抗生素保持有效,解决这一耐药机制的方法似乎至关重要。诸如法尼醇等萜烯醇已被证明可提高某些抗生素的疗效。然而,它们的高亲脂性使其难以使用。这个问题可以通过将它们封装在水分散性脂质纳米颗粒(LNPs)中来解决。本研究的目的是通过棋盘格试验和时间杀菌曲线实验,发现载于LNPs中的黏菌素与法尼醇或香叶醇之间的协同作用,这将提高黏菌素对特别是MCR - 1转接合子的疗效。然后,使用碘化丙啶(PI)摄取评估该组合对内膜通透性的影响,并与人类红细胞质膜通透性进行比较。两种萜烯醇都能够以相同的疗效(E = 16,即黏菌素的MIC从8mg/L降至0.5mg/L)恢复J53 MCR - 1对黏菌素 的敏感性。然而,法尼醇的效力更强,其EC为2.69mg/L,而香叶醇的EC为39.49mg/L。时间杀菌研究表明,孵育6小时后对MCR - 1转接合子有杀菌作用,在存在1mg/L黏菌素(1/8 MIC)和60mg/L或200mg/L法尼醇或香叶醇的情况下,直至30小时都没有再生长。单独使用黏菌素时,在敏感菌株中提高PI摄取率的效力(EC = 0.86±0.08mg/L)高于MCR - 1菌株(EC = 7.38±0.85mg/L)。对于MCR - 1菌株,60mg/L载有法尼醇的LNP将黏菌素诱导的内膜通透性增强作用提高了5倍,并且还提高了其效力,表现为其EC从7.38±0.85mg/L降至2.69±0.25mg/L。重要的是,在显示黏菌素MIC最大降低的浓度下,单独或与黏菌素组合的载有法尼醇或香叶醇的LNPs均未观察到溶血现象。此处呈现的结果表明,载有法尼醇的LNPs应作为与黏菌素的联合疗法进行研究,以防止对这种最后一道防线抗生素产生耐药性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d2/8625850/2e2a689e26a6/pharmaceutics-13-01849-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d2/8625850/3d0994a4ba00/pharmaceutics-13-01849-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d2/8625850/e7d142519d22/pharmaceutics-13-01849-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d2/8625850/9dba9e012fe9/pharmaceutics-13-01849-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d2/8625850/2e2a689e26a6/pharmaceutics-13-01849-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d2/8625850/3d0994a4ba00/pharmaceutics-13-01849-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d2/8625850/e7d142519d22/pharmaceutics-13-01849-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d2/8625850/9dba9e012fe9/pharmaceutics-13-01849-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d2/8625850/2e2a689e26a6/pharmaceutics-13-01849-g004.jpg

相似文献

1
Lipid Nanoparticles Loaded with Farnesol or Geraniol to Enhance the Susceptibility of MCR-1 to Colistin.负载法尼醇或香叶醇的脂质纳米颗粒以增强MCR-1对黏菌素的敏感性
Pharmaceutics. 2021 Nov 3;13(11):1849. doi: 10.3390/pharmaceutics13111849.
2
Rough-type and loss of the LPS due to lpx genes deletions are associated with colistin resistance in multidrug-resistant clinical Escherichia coli isolates not harbouring mcr genes.粗糙型和 LPS 缺失由于 lpx 基因缺失与不携带 mcr 基因的多药耐药临床大肠杆菌分离株中的多粘菌素耐药有关。
PLoS One. 2020 May 20;15(5):e0233518. doi: 10.1371/journal.pone.0233518. eCollection 2020.
3
MCR-1 Confers Cross-Resistance to Bacitracin, a Widely Used In-Feed Antibiotic.MCR-1 赋予了对杆菌肽(一种广泛使用的饲料用抗生素)的交叉耐药性。
mSphere. 2018 Sep 5;3(5):e00411-18. doi: 10.1128/mSphere.00411-18.
4
Colistin- and Carbapenem-Resistant Escherichia coli Harboring mcr-1 and blaNDM-5, Causing a Complicated Urinary Tract Infection in a Patient from the United States.携带mcr-1和blaNDM-5基因的耐黏菌素和耐碳青霉烯类大肠杆菌,导致一名美国患者发生复杂性尿路感染
mBio. 2016 Aug 30;7(4):e01191-16. doi: 10.1128/mBio.01191-16.
5
Silent transmission of an IS1294b-deactivated mcr-1 gene with inducible colistin resistance.携带可诱导性黏菌素耐药基因 mcr-1 的 IS1294b 失活元件的沉默传播。
Int J Antimicrob Agents. 2018 Jun;51(6):822-828. doi: 10.1016/j.ijantimicag.2018.01.004. Epub 2018 Jan 12.
6
Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1.黏菌素与阿米卡星联合使用对同时产生NDM-5和MCR-1的大肠杆菌的活性增强。
J Antimicrob Chemother. 2017 Jun 1;72(6):1723-1730. doi: 10.1093/jac/dkx038.
7
Prevalence of the colistin resistance gene mcr-1 in colistin-resistant Escherichia coli and Klebsiella pneumoniae isolated from humans in Thailand.泰国人源耐粘菌素大肠埃希菌和肺炎克雷伯菌中 mcr-1 耐药基因的流行情况。
J Glob Antimicrob Resist. 2018 Dec;15:32-35. doi: 10.1016/j.jgar.2018.06.007. Epub 2018 Jun 20.
8
A Review on Colistin Resistance: An Antibiotic of Last Resort.关于黏菌素耐药性的综述:一种最后的抗生素
Microorganisms. 2024 Apr 11;12(4):772. doi: 10.3390/microorganisms12040772.
9
[Investigation of Plasmid Mediated mcr Colistin Resistance Gene in Clinical Enterobacterales Isolates].临床分离肠杆菌科细菌中质粒介导的mcr多粘菌素耐药基因的研究
Mikrobiyol Bul. 2020 Apr;54(2):191-202. doi: 10.5578/mb.69021.
10
The inoculum effect of Escherichia coli expressing mcr-1 or not on colistin activity in a murine model of peritonitis.表达 mcr-1 或不表达 mcr-1 的大肠杆菌在腹膜炎小鼠模型中对黏菌素活性的接种效应。
Clin Microbiol Infect. 2019 Dec;25(12):1563.e5-1563.e8. doi: 10.1016/j.cmi.2019.08.021. Epub 2019 Sep 5.

本文引用的文献

1
Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane.黏菌素通过靶向细胞质膜中的脂多糖杀死细菌。
Elife. 2021 Apr 6;10:e65836. doi: 10.7554/eLife.65836.
2
Resveratrol enhances the antimicrobial effect of polymyxin B on Klebsiella pneumoniae and Escherichia coli isolates with polymyxin B resistance.白藜芦醇增强多黏菌素 B 对多黏菌素 B 耐药肺炎克雷伯菌和大肠埃希菌的抗菌作用。
BMC Microbiol. 2020 Oct 12;20(1):306. doi: 10.1186/s12866-020-01995-1.
3
Dual local drug delivery of vancomycin and farnesol for mitigation of MRSA infection in vivo - a pilot study.
万古霉素和法呢醇双重局部递药用于减轻体内耐甲氧西林金黄色葡萄球菌感染的初步研究。
Eur Cell Mater. 2020 Jul 16;40:38-57. doi: 10.22203/eCM.v040a03.
4
Epidemiology of mobile colistin resistance genes mcr-1 to mcr-9.移动性黏菌素耐药基因mcr-1至mcr-9的流行病学
J Antimicrob Chemother. 2020 Nov 1;75(11):3087-3095. doi: 10.1093/jac/dkaa205.
5
Sequential Time-Kill, a Simple Experimental Trick To Discriminate between Pharmacokinetics/Pharmacodynamics Models with Distinct Heterogeneous Subpopulations versus Homogenous Population with Adaptive Resistance.序贯时间杀菌法,一种简单的实验技巧,用于区分具有不同异质亚群的药代动力学/药效学模型与具有适应性耐药的同质群体。
Antimicrob Agents Chemother. 2020 Jul 22;64(8). doi: 10.1128/AAC.00788-20.
6
The rise and spread of plasmid-mediated polymyxin resistance.质粒介导的多粘菌素耐药性的出现和传播。
Crit Rev Microbiol. 2019 Mar;45(2):131-161. doi: 10.1080/1040841X.2018.1492902. Epub 2019 May 23.
7
Identification of Novel Mobilized Colistin Resistance Gene in a Multidrug-Resistant, Colistin-Susceptible Salmonella enterica Serotype Typhimurium Isolate.鉴定多药耐药但对黏菌素敏感的鼠伤寒沙门氏菌分离株中新型黏菌素移动耐药基因。
mBio. 2019 May 7;10(3):e00853-19. doi: 10.1128/mBio.00853-19.
8
Characterization of -Harboring subsp. Serovar Typhimurium Isolates from Animal and Food Origin in Germany.德国动物源和食品源 - 携带 亚属 血清型鼠伤寒沙门氏菌分离株的特性。
Antimicrob Agents Chemother. 2019 May 24;63(6). doi: 10.1128/AAC.00063-19. Print 2019 Jun.
9
Pharmacodynamic modelling of β-lactam/β-lactamase inhibitor checkerboard data: illustration with aztreonam-avibactam.β-内酰胺/β-内酰胺酶抑制剂棋盘数据的药效学模型:以阿佐米星-阿维巴坦为例。
Clin Microbiol Infect. 2019 Apr;25(4):515.e1-515.e4. doi: 10.1016/j.cmi.2018.11.025. Epub 2018 Dec 10.
10
Emergence of a novel mobile colistin resistance gene, mcr-8, in NDM-producing Klebsiella pneumoniae.产新德里金属β-内酰胺酶(NDM)肺炎克雷伯菌中新型可移动黏菌素耐药基因 mcr-8 的出现。
Emerg Microbes Infect. 2018 Jul 4;7(1):122. doi: 10.1038/s41426-018-0124-z.